The Hindu - International

Vaccine for dengue may be out in markets by mid2026, says IIL

- R. Sujatha

Vaccine for dengue could be available commercial­ly as early as mid2026. Indian Immunologi­cals Ltd. (IIL) has finished the first phase of clinical trials to determine the safety of the vaccine, the company’s managing director K. Anand Kumar said. The second and third phases of trials to test the vaccine’s efficacy are expected to begin shortly. IIL is a wholly owned subsidiary of the National Dairy Developmen­t Board, establishe­d in 1982.

“We have completed phase 1 trial, [which is] to determine safety. It was very successful. There have been no adverse reports. We will start phase 2 and 3 trials soon,” Dr. Kumar said in an interactio­n with The Hindu in Chennai over the

Phase 1 trial, to ensure safety, has been completed; phases to test efficacy will start soon

past weekend.

The findings of the first phase have already been published in peerreview­ed journals, he said. “We should have completed the trial in December but it was delayed by a few months. We wanted to release it in early 2026 but now, may be by mid2026, we will be ready to release the vaccines,” he added.

“For dengue, we got the virus strains from the National Institute of Virology. We will release the results of the clinical trials,” he explained of the protocol requiremen­ts for any such scientific work.

The company is also developing a vaccine for the Zika virus and for the Kyasanur Forest Disease (KFD).

The virus, first identified in 1957 in Karnataka’s forests, is reported to have infected 400 to 500 people annually since then. Transmissi­on in humans occurs through an infected tick’s bite or due to contact with an infected animal, especially a sick or dead monkey.

“The ICMR (Indian Council of Medical Research) has agreed in principle to help undertake, bear all the cost for clinical trials for the Zika vaccine and we are discussing codevelopi­ng the vaccine for KFD along with the Council,” Dr. Kumar said.

In January this year, the company launched the Hepatitis A vaccine, Havisure. The product has taken off well, Dr. Kumar said.

Newspapers in English

Newspapers from India